Skip to content
OpenCapital
Get started

Revelation Biosciences, Inc. REVB Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$2.71Miss by $1.56
EPS estimate-$1.15

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.83

Versus estimates

Revenue

Q4 2024$27.0K

Diluted EPS

Q1 2026-$2.71Miss by $1.56
Q4 2025-$1.65Beat by $2.01Q3 2025-$7.08Miss by $1.72Q2 2025-$7.01Miss by $2.55Q1 2025-$6.33Beat by $14.31Q4 2024-$14.94Miss by $5.34

Ask the moment Revelation Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Revelation Biosciences, Inc. report Q1 2026 earnings?
Revelation Biosciences, Inc. (REVB) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Revelation Biosciences, Inc.'s Q1 2026 revenue and EPS?
Revelation Biosciences, Inc. reported eps of $-2.71 for Q1 2026.
Did Revelation Biosciences, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-1.15 by $1.56.
How did Revelation Biosciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 57.2% from $-6.33.
Where can I find Revelation Biosciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-212064) and the 10-Q periodic report (0001193125-26-211871) directly on SEC EDGAR. The filing index links above go to sec.gov.